- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥24.9b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥53.60
7D
-13.2%
1Y
-30.6%
PharmaResources (Shanghai)
Market Cap: CN¥4.4b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥24.54
7D
-9.5%
1Y
-21.9%
AcrobiosystemsLtd
Market Cap: CN¥8.7b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥52.18
7D
0.7%
1Y
-7.9%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.4b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥22.96
7D
-8.3%
1Y
-31.9%
Xiamen Amoytop Biotech
Market Cap: CN¥23.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥57.59
7D
-4.3%
1Y
-25.6%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.8b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥44.73
7D
9.4%
1Y
1.2%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥6.7b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥12.36
7D
-2.0%
1Y
-24.6%